Scientific Research: Another gene therapy for flu? – FDA approves new mRNA vaccine despite risks!
"The FDA approval of mFLUSIVA, our fourth approved product in the United States and the first mRNA-based flu vaccine, demonstrates the continued strength and versatility of our mRNA platform,"
Manufactured by Moderna, the new flu mRNA vaccine "Will make it easier to rapidly target a new prevalent or virulent strain of the virus.""Do you want to take a new influenza mRNA vaccine to give you a 0.8% reduced chance of getting influenza?"
More in the Dr. John Campbell video.
Comments
Post a Comment